A kilometre of cores and counting: the mighty ITRAX
ITRAX has now analysed more than a kilometre of cores since it became operational in 2012.
 
  Showing 421 - 440 of 982 results
ITRAX has now analysed more than a kilometre of cores since it became operational in 2012.
 
      ANSTO sets out the following terms and conditions relating to users who access our facilities for the purpose of research.
 
Nick is a radiation biologist who works for the NST Human Health research theme.
 
Luis Abuel is a technical officer with a background in Instrumentation and Process Control Engineering. Luis started at ANSTO in May 2006 as an Instrumentation Technician in OPAL.
 
Recently, a small delegation, including Yandruwandha Yawarrawarrka representatives from the remote outback settlement of Innamincka SA, travelled to ANSTO to deliver rare wooden Aboriginal archaeological artefacts for measurements to determine their age and origin.
 
      The National Deuteration Facility offers access to deuterated molecules prepared by both in vivo biodeuteration and chemical deuteration techniques.
 
      ANSTO undertakes a rigorous environmental monitoring program and shares expertise nationally and internationally.
Research will change understanding of Australian Aboriginal rock art found in rock shelters of the Kimberley and its relationship to a changing landscape
 
 
Mr Andrew Carriline is an experienced senior business executive, commercially astute and highly skilled at operating successfully in regulated environments.
The Australian Nuclear Science and Technology Organisation (ANSTO) has joined a team, lead by the US Department of Energy’s Pacific Northwest National Laboratory (PNNL), to install a high resolution monitoring system at ANSTO’s medical isotope production facility in Lucas Heights, Australia.
ANSTO has provided supporting experimental evidence of a highly unusual quantum state, a quantum spin liquid (QSL), in a two-dimensional material.
 
      How to prepare samples for analysis on the Powder Diffraction beamline.
 
      Melbourne researchers map the structure of a key COVID-19 protein using the Australian Synchrotron